The peptide-derived drug, M3mP6 HLPN, prevents blood clots without increasing the risk of bleeding. 

The approval means Abiomed can stream patient data from its Impella heart pumps to remote monitoring platforms installed at more than 200 hospitals.

Results of the trial, which included more than 11,000 patients, were published in the New England Journal of Medicine.

The researchers tracked infection rates at Boston’s Mass General Brigham health system, which announced a plan to require all 78,000 employees to wear a surgical mask in March.

The risk score was found to be considerably accurate, providing results that matched the work of prior researchers.

Late gadolinium enhancement was associated with a greater risk of experiencing major cardiac events, including sudden cardiac death.

The solution, Caption AI, was designed to help users “without lengthy specialized training” capture high-quality images.  

LDCT has been a hot topic in the news lately, with U.S. lawmakers recently pushing for greater efforts to expand use of this lifesaving clinical tool.